Epidemiology of Thyroid Cancer

  • James J. Figge

Abstract

Thyroid cancer is the most common endocrine malignancy, accounting for 1.9% of all new malignant tumors (excluding skin cancer and in situ carcinomas) diagnosed annually in the United States (0.92% of cancers in men; 2.9% in women; 1). Annual incidence rates vary by geographic area, age, and sex. The age-adjusted annual incidence (from 1996 to 2000) in the United States is 68 new cases per million (2,3), with a higher incidence in women (99/million) than men (36/million) (2,4). Approximately 25,690 new cases of thyroid cancer are now diagnosed annually in the United States with a female_male ratio close to 3:1 (1). Worldwide, incidence rates are highest in certain geographic areas, such as Hawaii (119/million women and 45/million men), probably as a result of local environmental influences (2,5). Rates in Poland are among the lowest recorded: 14 per million women and four per million men (6). Thyroid cancer is very rare in children under age 15. The annual U.S. incidence in this population is 2.2 per million girls and 0.9 per million boys (7). The annual incidence of thyroid cancer increases with age, peaking between 100 and 120 per million by the fifth through eighth decades (2).

References

  1. 1.
    Jemal A, Murray T, Ward E, et al. American Cancer Society. Cancer Statistics, 2005. CA Cancer J Clin 2005; 55:10–30.PubMedGoogle Scholar
  2. 2.
    Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. eds. SEER Cancer Statistics Review, 1975–2000, National Cancer Institute, Bethesda, MD, 2003. Available at: seer.cancer.tigov/csr/1975_2000/.Google Scholar
  3. 3.
    Verby JE, Woolner LB, Nobrega FT, Kurland LT, McConahey WM. Thyroid cancer in Olmsted County, 1935–1965. J Natl Cancer Inst 1969; 43:813–820.PubMedGoogle Scholar
  4. 4.
    Polednak AP. Trends in cancer incidence in Connecticut, 1935–1991. Cancer 1994; 74:2863–2872.PubMedCrossRefGoogle Scholar
  5. 5.
    Goodman MT, Yoshizawa CN, Kolonel LN. Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 1988; 61:1272–1281.PubMedCrossRefGoogle Scholar
  6. 6.
    Whelan SL, Parkin DM, Masuyer E. Patterns of cancer in five continents. IARC Sci Publ 1990; 102:1–159.Google Scholar
  7. 7.
    Parkin DM, Stiller CA, Draper GJ, Bieber CA. International incidence of childhood cancer. IARC Sci Publ 1988; 87:1–401.Google Scholar
  8. 8.
    Weiss W. Changing incidence of thyroid cancer. J Natl Cancer Inst 1979; 62:1137–1142.PubMedGoogle Scholar
  9. 9.
    Pottern LM, Stone BJ, Day NE, Pickle LW, Fraumeni JF Jr. Thyroid cancer in Connecticut, 1935–1975: an analysis by cell type. Am J Epidemiol 1980; 112:764–774.PubMedGoogle Scholar
  10. 10.
    Carroll RE, Haddon W Jr, Handy VH, Wieben EE. Thyroid cancer: cohort analysis of increasing incidence in New York State, 1941–1962. J Natl Cancer Inst 1964; 33:277–283.PubMedGoogle Scholar
  11. 11.
    Waterhouse J, Muir C, Correa P, Powell J. Cancer Incidence in Five Continents, vol. 3. Lyon, France: International Agency for Research on Cancer, 1976.Google Scholar
  12. 12.
    Waterhouse J, Muir C, Shanugaratnam K. Cancer Incidence in Five Continents, vol. 4. Lyon, France: International Agency for Research on Cancer, 1982.Google Scholar
  13. 13.
    Pettersson B, Adami H-O, Wilander E, Coleman MP. Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 1991; 48:28–33.PubMedGoogle Scholar
  14. 14.
    dos Santos Silva I, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993; 67:330–340.PubMedGoogle Scholar
  15. 15.
    Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. Int J Cancer 1993; 53:183–187.PubMedCrossRefGoogle Scholar
  16. 16.
    Glattre E, Akslen LA, Thoresen S, Haldoren T. Geographic patterns and trends in the incidence of thyroid cancer in Norway 1970–1986. Cancer Detect Prev 1990; 14:625–631.PubMedGoogle Scholar
  17. 17.
    Hrafnkelsson J, Jonasson JG, Sigurdsson G, Sigvaldason H, Tulinius H. Thyroid cancer in Iceland 1955–1984. Acta Endocrinol 1988; 118:566–572.PubMedGoogle Scholar
  18. 18.
    Staunton MD, Bourne H. Thyroid cancer in the 1980’s: a decade of change. Ann Acad Med (Singapore) 1993; 22:613–616.Google Scholar
  19. 19.
    Levi F, Franceschi S, Te VC, Negri E, La Vecchia C. Descriptive epidemiology of thyroid cancer in the Swiss canton of Vaud. J Cancer Res Clin Oncol 1990; 116:639–647.PubMedCrossRefGoogle Scholar
  20. 20.
    Roush GC, Holford TR, Schymura MJ, White C. Cancer Risk and Incidence Trends: The Connecticut Perspective. New York: Hemisphere Publishing, 1987.Google Scholar
  21. 21.
    Sarne D, Schneider AB. External radiation and thyroid neoplasia. Endocrinol Metab Clin North Am 1996; 25:181–195.PubMedCrossRefGoogle Scholar
  22. 22.
    Mortensen JD, Bennett WA, Woolner LB. Incidence of carcinoma in thyroid glands removed at 1000 consecutive routine necropsies. Surg Forum 1954; 5:659–663.Google Scholar
  23. 23.
    Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955; 15:1270–1280.PubMedGoogle Scholar
  24. 24.
    Bisi H, Fernandes VS, de Camargo RY, Koch L, Abdo AH, de Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer 1989; 64:1888–1893.PubMedCrossRefGoogle Scholar
  25. 25.
    Silverberg SG, Vidone RA. Carcinoma of the thyroid in surgical and postmortem material: analysis of 300 cases at autopsy and literature review. Ann Surg 1966; 164:291–299.PubMedCrossRefGoogle Scholar
  26. 26.
    VanderLaan WP. The occurrence of carcinoma of the thyroid gland in autopsy material. N Engl J Med 1947; 237:221–222.PubMedCrossRefGoogle Scholar
  27. 27.
    LiVolsi VA. Papillary neoplasms of the thyroid. Am J Clin Pathol 1992; 97:426–434.PubMedGoogle Scholar
  28. 28.
    Ain KB. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1995; 24:711–760.PubMedGoogle Scholar
  29. 29.
    Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M. Papillary carcinoma. Semin Diagn Pathol 1985; 2:90–100.PubMedGoogle Scholar
  30. 30.
    Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer 1987; 60:1767–1770.PubMedCrossRefGoogle Scholar
  31. 31.
    Naruse T, Koike A, Kanemitsu T, Kato K. Minimal thyroid carcinoma: a report of nine cases discovered by cervical lymph node metastases. Jpn J Surg 1984; 14:118–121.PubMedCrossRefGoogle Scholar
  32. 32.
    Noguchi M, Tanaka S, Akiyama T, Miyazaki I, Michigishi T, Tonami N, et al. Clinicopathological studies of minimal thyroid and ordinary thyroid cancers. Jpn J Surg 1984; 14:110–117.PubMedCrossRefGoogle Scholar
  33. 33.
    Yamashita H, Nakayama I, Noguchi S, Murakami N, Moriuchi A, Yokoyama S, et al. Thyroid carcinoma in benign thyroid diseases: an analysis from minute carcinoma. Acta Pathol Jpn 1985; 35:781–788.PubMedGoogle Scholar
  34. 34.
    Harach HR, Franssila KO, Wasenius V-M. Occult papillary carcinoma of the thyroid—a “normal” finding in Finland: a systematic autopsy study. Cancer 1985; 56:531–538.PubMedCrossRefGoogle Scholar
  35. 35.
    Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975; 36:1095–1099.PubMedCrossRefGoogle Scholar
  36. 36.
    Sampson RJ. Prevalence and significance of occult thyroid cancer. In DeGroot LJ, editor. Radiation-Associated Thyroid Carcinoma. New York: Grune & Stratton, 1997:137–153.Google Scholar
  37. 37.
    Sampson RJ, Woolner LB, Bahn RC, Kurland LT. Occult thyroid carcinoma in Olmsted county, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 1974; 34:2072–2076.PubMedCrossRefGoogle Scholar
  38. 38.
    Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer 1984; 54:1093–1100.PubMedCrossRefGoogle Scholar
  39. 39.
    Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut tumor registry. N Engl J Med 1986; 315:1394–1397.PubMedCrossRefGoogle Scholar
  40. 40.
    Lohrs U, Permanetter W, Spelsberg F, Beitinger M. Investigation of frequency and spreading of the different histological types of thyroid cancer in an endemic goiter region. Verhandl Dtsch Ges Pathol 1977; 61:268–274.Google Scholar
  41. 41.
    Harach HR, Escalante DA, Onativa A, Lederer Outes J, Saravia Day E, Williams ED. Thyroid carcinoma and thyroiditis in an endemic goiter region before and after iodine prophylaxis. Acta Endocrinol 1985; 108:55–60.PubMedGoogle Scholar
  42. 42.
    Farahati J, Geling M, Mader U, Mortl M, Luster M, Muller JG, et al. Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981–1995. Thyroid 2004; 14:141–147.PubMedCrossRefGoogle Scholar
  43. 43.
    Mazzaferri EL. Thyroid cancer. In Becker KL, editor. Principles and Practice of Endocrinology and Metabolism, 3rd ed. Philadelphia: Lippincott, Wiiliams & Wilkins, 2001:382–402.Google Scholar
  44. 44.
    Ledger GA, Khosla S, Lindor NM, Thibodeau SN, Gharib H. Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med 1995; 122:118–124.PubMedGoogle Scholar
  45. 45.
    Emmertsen K. Medullary thyroid carcinoma and calcitonin. Dan Med Bull 1985; 32:1–28.PubMedGoogle Scholar
  46. 46.
    Mazzaferri EL, Oertel YC. Primary malignant lymphoma and related lymphoproliferative disorders. In Mazzaferri EL, Samaan NA, editors. Endocrine Tumors. Cambridge, MA: Blackwell Scientific, 1993:348.Google Scholar
  47. 47.
    Anscombe AM, Wright DH. Primary malignant lymphoma of the thyroid-a tumor of mucosa-associated lymphoid tissue: review of seventy six cases. Histopathology 1985; 9:81–97.PubMedCrossRefGoogle Scholar
  48. 48.
    Kravdal O, Glattre E, Haldorsen T. Positive correlation between parity and incidence of thyroid cancer: new evidence based on complete Norwegian birth cohorts. Int J Cancer 1991; 49:831–836.PubMedCrossRefGoogle Scholar
  49. 49.
    Glattre E, Kravdal O. Male and female parity and risk of thyroid cancer. Int J Cancer 1994; 58:616–617.PubMedCrossRefGoogle Scholar
  50. 50.
    Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr. A population-based case-control study of thyroid cancer. J Natl Cancer Inst 1987; 79:1–12.PubMedGoogle Scholar
  51. 51.
    Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312:601–604.PubMedCrossRefGoogle Scholar
  52. 52.
    Wegelin C. Malignant disease of the thyroid gland and its relation to goiter in men and animals. Cancer Rev 1928; 3:297.Google Scholar
  53. 53.
    Franceschi S, Fassina A, Talamini R, Mazzolini A, Vianello S, Bidoli E, et al. Risk factors for thyroid cancer in northern Italy. Int J Epidemiol 1989; 18:578–584.PubMedCrossRefGoogle Scholar
  54. 54.
    Franceschi S, Talamini R, Fassina A, Bidoli E. Diet and epithelial cancer of the thyroid gland. Tumori 1990; 76:331–338.PubMedGoogle Scholar
  55. 55.
    Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1990; 1:223–234.PubMedCrossRefGoogle Scholar
  56. 56.
    Glattre E, Haldorsen T, Berg JP, Stensvold I, Solvoll K. Norwegian case-control study testing the hypothesis that seafood increases the risk of thyroid cancer. Cancer Causes Control 1993; 4:11–16.PubMedCrossRefGoogle Scholar
  57. 57.
    Preston-Martin S, Jin F, Duda MJ, Mack WJ. A case-control study of thyroid cancer in women under age 55 in Shanghai (People’s Republic of China). Cancer Causes Control 1993; 4:431–440.PubMedCrossRefGoogle Scholar
  58. 58.
    Hallquist A, Hardell L, Degerman A, Boquist L. Thyroid cancer: reproductive factors, previous diseases, drug intake, family history and diet: a case-control study. Eur J Cancer Prev 1994; 3:481–488.PubMedCrossRefGoogle Scholar
  59. 59.
    Franceschi S, Levi F, Negri E, Fassina A, LaVecchia C. Diet and thyroid cancer: a pooled analysis of four European case-control studies. Int J Cancer 1991; 48:395–398.PubMedCrossRefGoogle Scholar
  60. 60.
    Correa P, Llanos G. Morbidity and mortality from cancer in Cali, Columbia. J Natl Cancer Inst 1966; 36:717–745.PubMedGoogle Scholar
  61. 61.
    Franssila K, Saxen E, Teppo L, Bjarnason O, Tulinius H, Norman T, Ringertz N. Incidence of different morphological types of thyroid cancer in the Nordic countries. Acta Pathol Microbiol Scand A 1981; 89:49–55.PubMedGoogle Scholar
  62. 62.
    Pendergrast WJ, Milmore BK, Marcus SC. Thyroid cancer and thyrotoxicosis in the United States: their relation to endemic goiter. J Chronic Dis 1961; 13:22–38.PubMedCrossRefGoogle Scholar
  63. 63.
    Beahrs OH, Pemberton JJ, Black BM. Nodular goiter and malignant lesions of the thyroid gland. J Clin Endocrinol 1951; 11:1157–1165.Google Scholar
  64. 64.
    Pemberton J, Black BM. The association of carcinoma of the thyroid gland and exophthalmic goiter. Surg Clin North Am 1948; 28:935–952.PubMedGoogle Scholar
  65. 65.
    Olen E, Klinck GH. Hyperthyroidism and thyroid cancer. Arch Pathol 1966; 81:531–535.PubMedGoogle Scholar
  66. 66.
    Sokal JE. Incidence of malignancy in toxic and non-toxic nodular goiter. JAMA 1954; 154:1321–1325.Google Scholar
  67. 67.
    Carnell NE, Valente WA. Thyroid nodules in Graves’ disease: classification, characterization, and response to treatment. Thyroid 1998; 8:647–652.PubMedCrossRefGoogle Scholar
  68. 68.
    Shapiro SJ, Friedman NB, Perzik SI, Catz B. Incidence of thyroid carcinoma in Graves’ disease. Cancer 1970; 26:1261–1270.PubMedCrossRefGoogle Scholar
  69. 69.
    Wahl RA, Goretzki P, Meybier H, Nitschke J, Linder M, Roher HD. Coexistence of hyperthyroidism and thyroid cancer. World J Surg 1982; 6:385–390.PubMedCrossRefGoogle Scholar
  70. 70.
    Farbota LM, Calandra DB, Lawrence AM, Paloyan E. Thyroid carcinoma in Graves’ disease. Surgery 1985; 98:1148–1153.PubMedGoogle Scholar
  71. 71.
    Behar R, Arganini M, Wu TC, McCormick M, Straus FH, DeGroot LJ, Kaplan EL. Graves’ disease and thyroid cancer. Surgery 1986; 100:1121–1127.PubMedGoogle Scholar
  72. 72.
    Pacini F, Elisei R, Di Coscio GC, Anelli S, Macchia E, Concetti R, et al. Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest 1988; 11:107–112.PubMedGoogle Scholar
  73. 73.
    Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves’ disease. World J Surg 1990; 14:437–440.PubMedCrossRefGoogle Scholar
  74. 74.
    Belfiore A, Garofalo MR, Giuffrida D, Runello F, Filetti S, Fiumara A, et al. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J Clin Endocrinol Metab 1990; 70:830–835.PubMedCrossRefGoogle Scholar
  75. 75.
    Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, et al. Does Graves’ disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 1992; 75:886–889.PubMedCrossRefGoogle Scholar
  76. 76.
    Cady B. Papillary carcinoma of the thyroid. Semin Surg Oncol 1991; 7:81–86.PubMedCrossRefGoogle Scholar
  77. 77.
    Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990; 50:2283–2289.PubMedGoogle Scholar
  78. 78.
    Levi F, Franceschi S, La Vecchia C, Negri E, Gulie C, Duruz G, Scazziga B. Previous thyroid disease and risk of thyroid cancer in Switzerland. Eur J Cancer 1991; 27:85–88.PubMedCrossRefGoogle Scholar
  79. 79.
    Preston-Martin S, Bernstein L, Pike MC, Maldonado AA, Henderson BE. Thyroid cancer among young women related to prior thyroid disease and pregnancy history. Br J Cancer 1987; 55:191–195.PubMedGoogle Scholar
  80. 80.
    Wingren G, Hatschek T, Axelson O. Determinants of papillary cancer of the thyroid. Am J Epidemiol 1993; 138:482–491.PubMedGoogle Scholar
  81. 81.
    McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to previous exposure to radiation therapy and history of thyroid disease. J Natl Cancer Inst 1984; 73:575–581.PubMedGoogle Scholar
  82. 82.
    Negri E, Ron E, Franceschi S, Dal Maso L, Mark SD, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. I. Methods. Cancer Causes Control 1999; 10:131–142.PubMedCrossRefGoogle Scholar
  83. 83.
    Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999; 10:143–155.PubMedCrossRefGoogle Scholar
  84. 84.
    La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 1999; 10:157–166.PubMedCrossRefGoogle Scholar
  85. 85.
    Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999; 10:583–595.PubMedCrossRefGoogle Scholar
  86. 86.
    Preston-Martin S, Franceschi S, Ron E, Negri E. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned? Cancer Causes Control 2003; 14:787–789.PubMedCrossRefGoogle Scholar
  87. 87.
    Mellemgaard A, From G, Jorgensen T, Johansen C, Olsen JH, Perrild H. Cancer risk in individuals with benign thyroid disorders. Thyroid 1998; 8:751–754.PubMedGoogle Scholar
  88. 88.
    From G, Mellemgaard A, Knudsen N, Jorgensen T, Perrild H. Review of thyroid cancer cases among patients with previous benign thyroid disorders. Thyroid 2000; 10:697–700.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • James J. Figge
    • 1
    • 2
  1. 1.Department of Biomedical Sciences, School of Public HealthState University of New YorkNew York
  2. 2.Capital District Physicians’ Health Plan and Department of MedicineSt. Peter’s Hospital and Albany Medical Center HospitalAlbany

Personalised recommendations